Cargando…

COVID-19 With Preexisting Hypercoagulability Digestive Disease

The outbreak of coronavirus disease of 2019 (COVID-19) has become a global public health and economic crisis. The advent of hypercoagulability and thrombotic complications can substantially influence the prognosis of COVID-19 patients. In this review, we elaborate on the clinical findings, potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Mingshan, Mu, Jingxi, Shen, Silan, Zhang, Hu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838325/ https://www.ncbi.nlm.nih.gov/pubmed/33521013 http://dx.doi.org/10.3389/fmed.2020.587350

Ejemplares similares

COVID-19-Induced Hypercoagulability: A Case Report
por: Sperry, Bailey, et al.
Publicado: (2022)

Editorial: COVID-19 and the Digestive System
por: Ma, Chunxiang, et al.
Publicado: (2022)

Hypercoagulable State in COVID-19: A Case Series of Three Patients
por: Logan, Gideon, et al.
Publicado: (2020)

Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease
por: Gurala, Dhineshreddy, et al.
Publicado: (2020)

Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Wu, Xianbo, et al.
Publicado: (2021)

Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients
por: Iaccarino, Guido, et al.
Publicado: (2021)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability
por: Burley, Nicholas B, et al.
Publicado: (2021)

Pregnancy in Women With Preexisting Glomerular Diseases: A Single-Center Experience
por: Marinaki, Smaragdi, et al.
Publicado: (2022)

Hypercoagulation from Concomitant Administration of Tamoxifen and Warfarin
por: Panahi, Ladan, et al.
Publicado: (2020)

COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020)

COVID-19 versus HIT hypercoagulability
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

COVID-19 and hypercoagulability in the outpatient setting
por: Emert, Roger, et al.
Publicado: (2020)

People having hematological disorders and hypercoagulability state need extra precautions because of the increased risk of thrombosis after COVID-19 vaccination
por: Aydemir, Duygu, et al.
Publicado: (2023)

Hypercoagulability Due to COVID-19 Leading to Impending Phlegmasia Cerulea Dolens and Sub-Massive Bilateral Pulmonary Embolism
por: Moraes, Bruno, et al.
Publicado: (2021)

Preexisting prediabetes and the severity of COVID-19
por: Sathish, Thirunavukkarasu, et al.
Publicado: (2021)

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders
por: Coureau, Michelle, et al.
Publicado: (2020)

Thrombotic and Hypercoagulability Complications of COVID-19: An Update
por: Shibeeb, Sapha, et al.
Publicado: (2021)

HYPERCOAGULABLE STATE: AN ENIGMA IN COVID-19 INFECTION
por: MILI, SAIMA, et al.
Publicado: (2021)

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)

Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities
por: Zhang, Yun, et al.
Publicado: (2023)

COVID-19 and ischemic stroke: Mechanisms of hypercoagulability (Review)
por: Zhang, Shuoqi, et al.
Publicado: (2021)

COVID-19 in Africa: preexisting immunity and HIV
por: Snyman, Jumari, et al.
Publicado: (2021)

Management and Perspective of Coronavirus Disease 2019 (COVID-19), Pregnancy, and Hypercoagulability
por: Nasir, Umair, et al.
Publicado: (2021)

82 Heparinase-Native Thromboelastometry Detects Hypercoagulability in COVID-19 Disease
por: Maher, P.J., et al.
Publicado: (2021)

Cocaine-Induced Four-Extremity Ischemia Caused by a Hypercoagulable State
por: Echevarria, Victoria, et al.
Publicado: (2023)

Characteristics of COVID-19 patients with preexisting CKD history
por: Xu, Chuou, et al.
Publicado: (2021)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

Long lasting hypercoagulability after subclinical COVID-19
por: Ferroli, Paolo, et al.
Publicado: (2020)

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
por: Abou-Ismail, Mouhamed Yazan, et al.
Publicado: (2020)

Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Lorenzo, Cerruti, et al.
Publicado: (2020)

Clinical Features and Management of COVID-19–Associated Hypercoagulability
por: Massaro, Gianluca, et al.
Publicado: (2022)

Hypercoagulability of COVID-19 and Neurological Complications: A Review
por: Moore, Patrick, et al.
Publicado: (2022)

Re: Late diagnosis of COVID-19 and hypercoagulable state
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Response to late diagnosis of COVID-19 and hypercoagulable state
por: Desdiani, Desdiani
Publicado: (2022)

Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease
por: Verma, Nipun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d5t9cttskcooo12iajhno0udcc